COVID-19 Updates | EU, UK, US
The AstraZeneca COVID-19 vaccine, recently renamed Vaxzevria, made headlines this week in Europe, due to rising concerns over the links with its use and the development of blood clots. The European Medicines Agency (EMA) again reviewed the data on the reported cases and published another opinion on 7 April 2021, confirming there is a potential link with “very rare cases of unusual blood clots with low blood platelets”. While the EMA’s safety committee recognized that some of the blood clots cases are linked to the vaccine, it stressed,
“[T]he overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects”. The EMA confirmed that unusual blood clots should be listed as a very rare side effect, but considering the benefits of the vaccine overall, it remains approved in the EU for people above 18 years old.
Blinken, Raab express support for Ukraine parisguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from parisguardian.com Daily Mail and Mail on Sunday newspapers.
There is a need for a military as well as a developmental approach to Cabo Delgado conflict
Share
There is no question that the insurgency in Cabo Delgado in the north of Mozambique is far from over. While the military has secured the town of Palma that was attacked on March 24, insurgents have withdrawn to regroup, moved to nearby areas with fresh supplies, and remain an imminent threat to the Cabo Delgado region.
The SADC held an Extraordinary Double Troika Summit on Thursday to discuss the way forward and concretise a regional strategy to deal with the security threat that has become a major concern not only for Mozambique, but for its neighbours and the international community.
There is need for military as well as developmental approach to Cabo Delgado conflict thezimbabwemail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thezimbabwemail.com Daily Mail and Mail on Sunday newspapers.